Company Filing History:
1 out of 3,540 
1 out of 870 
1 out of 5,094 
Years Active: 2005-2008
Title: Artur Scherf: Innovator in Malaria Research
Introduction
Artur Scherf is a prominent inventor based in Paris, France. He has made significant contributions to the field of malaria research, particularly in understanding the mechanisms of Plasmodium falciparum, the parasite responsible for the most severe form of malaria. With a total of 2 patents, Scherf's work focuses on the proteins involved in the cytoadhesion of infected erythrocytes and the development of diagnostic methods and vaccines.
Latest Patents
Scherf's latest patents include groundbreaking inventions related to malaria. One patent details the RSP-1 and RSP-2 proteins, which are crucial for the cytoadhesion of ring-stage-infected erythrocytes. This invention also encompasses antibodies that bind to these proteins, methods for detecting infections, determining the stage of infection, and vaccines aimed at protecting against malaria. Another patent focuses on the identification of a var gene and its corresponding protein that modulates the adhesion of parasitized red blood cells to chondroitin sulfate A. This discovery opens avenues for novel biological tools, prophylactics, therapeutics, diagnostics, and methods of use.
Career Highlights
Artur Scherf has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Institut Pasteur. His research has significantly advanced the understanding of malaria and has the potential to impact public health positively.
Collaborations
Scherf has collaborated with notable colleagues in his field, including Pierre Buffet and Bruno Pouvelle. These partnerships have fostered innovative research and development in malaria diagnostics and treatment.
Conclusion
Artur Scherf's contributions to malaria research through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in the fight against malaria, ultimately aiming to improve health outcomes worldwide.